Hyloris Pharmaceuticals أخبار Eulerpool

Hyloris Pharmaceuticals إيولربول AFX

أخبار سهم Hyloris Pharmaceuticals

يتابع Hyloris Pharmaceuticals العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Hyloris Pharmaceuticals.

• ١٤ مارس ·

  Yahoo
  Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
• ١٤ مارس ·

  Yahoo
  Communication at the request of the FSMA on the transactions with Qliniq
• ٨ مارس ·

  Yahoo
  Hyloris to Report 2023 Full-Year Results on 14 March 2024
• ٢٧ فبراير ·

  Yahoo
  Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada
• ١٤ فبراير ·

  Yahoo
  Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures
• ٣٠ يناير ·

  Yahoo
  Hyloris and Purna Female Healthcare Announce Positive Results from Phase 2 Trial in Patients with Acute Vulvovaginal Candidiasis (VVC)
• ١٨ يناير ·

  Yahoo
  Hyloris Broadens Pipeline with new Product Candidate for Vulvar Lichen Sclerosus (VLS)
• ١٦ يناير ·

  Yahoo
  Orphan Drug Designation Granted to PTX-252 by U.S. FDA for the Treatment of Acute Myeloid Leukaemia (AML)
• ١٦ يناير ·

  Yahoo
  Pleco Therapeutics receives FDA Orphan Drug Designation
• ٢٦ ديسمبر ·

  Yahoo
  Hyloris Announces Positive Clinical Study Results for Valacyclovir Oral Suspension (HY-029)